pharmacologic therapy for covid-19 infection. ¬© 2020, This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.The COVID-19 pandemic has focused attention on issues of epidemiology, public health, and vaccine design. I submit that attention to COVID-19 pharmacologic therapy needs similar emphasis, including identifying any existing medications that can be repurposed to treat COVID-19 patients.